DICE Therapeutics Inc. Gains 62.27%
Tue, Oct 11, 2022 at 07:52 PM
DICE Therapeutics Inc. (DICE:NASDAQ) jumped higher at $40, a gain of 62.3%. On Tue, Oct 11, 2022, DICE:NASDAQ hit a New 2-Week High of $40. The stock appeared on our News Catalysts scanner on Tue, Oct 11, 2022 at 05:34 PM in the 'PUBLIC OFFERING' category. From Tue, Sep 27, 2022, the stock recorded 80.00% Up Days and 72.73% Green Days
About DICE Therapeutics Inc. (DICE:NASDAQ)
DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and...
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 107.65%
- DICE Therapeutics Inc. (DICE:NASDAQ), 62.27%
- Immunic, Inc. (IMUX:NASDAQ), 51.77%
- ForgeRock Inc. Class A (FORG:NYSE), 48.55%
- Laser Photonics Corporation (LASE:NASDAQ), 44.39%
- scPharmaceuticals Inc. (SCPH:NASDAQ), 39.3%
- Oblong Inc. (OBLG:NASDAQ), 38.63%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 35.27%
- Meiwu Technology Company Limited (WNW:NASDAQ), 33.74%
- Agrify Corporation (AGFY:NASDAQ), 32.62%